4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Smoking Cessation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bullen, C; Cobb, CO; Eissenberg, T; Foulds, J; Kang, L; Lopez, AA; Veldheer, S; Yen, MS; Yingst, JM | 1 |
| Peres, J | 1 |
| Anderson, A; Broadbent, B; Carmella, S; Hatsukami, DK; Hecht, SS; Jensen, J; Murphy, SE; Severson, H; Vogel, RI | 1 |
| Benowitz, NL; Bronars, C; Day, G; Decker, PA; Flanagan, CA; Hatsukami, DK; Hughes, C; Koller, KR; Murphy, NJ; Patten, CA; Renner, CC; Thomas, TK; Wolfe, AW | 1 |
| Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J | 1 |
| Gregg, EO; Lowe, FJ; McEwan, M | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I | 1 |
| Bagkeris, E; Chatzi, L; Connolly, GN; Fthenou, E; Hecht, SS; Kogevinas, M; Murphy, S; Patelarou, E; Vardavas, CI | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Kramarczuk, I; Le, C; Li, YS; Losey, L; Murphy, SE; Puumala, SS; Roe, MR; Zimmerman, CL | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Le, C; Link, CA; Losey, L; Murphy, SE; Puumala, SS | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Joseph, AM; Le, CT; Mooney, ME; Zhang, Y | 1 |
| Babb, D; Hatsukami, D; Hecht, S; LeSage, M; Mooney, M; Murphy, S | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Le, C; Luo, X; Mooney, M; Murphy, SE; Riley, WT | 1 |
| Bliss, R; Carmella, SG; Gross, M; Hatsukami, DK; Hecht, SS; Joseph, AM; Lando, H; Le, CT; Murphy, SE | 1 |
9 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Smoking Cessation
| Article | Year |
|---|---|
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Topics: Adult; Carcinogens; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Smoking Cessation | 2021 |
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Topics: Administration, Oral; Adult; Biomarkers; Chewing Gum; Consumer Behavior; Cotinine; Female; Glucuronides; Humans; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Nitrosamines; Oregon; Pyridines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Urinalysis | 2016 |
Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
Topics: Adult; Biomarkers; Carcinogens; Cotinine; Female; Humans; Infant, Newborn; Nitrosamines; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Young Adult | 2016 |
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult | 2017 |
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult | 2011 |
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Topics: Adult; Aged; Alkaloids; Biomarkers, Tumor; Carcinogens; Cotinine; Female; Glucuronates; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosamines; Pyridines; Research Design; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Topics: Adult; Alkaloids; Biomarkers; Carcinogens; Endpoint Determination; Environmental Exposure; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Reproducibility of Results; Smoking; Smoking Cessation; Urinalysis | 2004 |
Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Carcinogens; Cotinine; Creatinine; Female; Humans; Male; Middle Aged; Nitrosamines; Pyridines; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco, Smokeless | 2007 |
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention | 2008 |
5 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Smoking Cessation
| Article | Year |
|---|---|
Water pipe smoking: not risk free.
Topics: Adult; Carcinogens; Cotinine; Environmental Exposure; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Recreation; Smoking; Smoking Cessation; Students; United States; Young Adult | 2014 |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Cholesterol, LDL; Cross-Sectional Studies; Deoxyguanosine; Dinoprost; Female; Humans; Immunoglobulin G; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Reproducibility of Results; Smoke; Smoking; Smoking Cessation; Thromboxane B2; Thymidine | 2009 |
Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Topics: Air Pollution, Indoor; Biomarkers; Cotinine; Environmental Exposure; Environmental Monitoring; Female; Follow-Up Studies; Humans; Nitrosamines; Pregnancy; Pyridines; Self Report; Smoking; Smoking Cessation; Specimen Handling; Spouses; Tobacco Smoke Pollution | 2013 |
Toxicant exposure in cigarette reducers versus light smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Chewing Gum; Environmental Exposure; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation | 2006 |
Effects of high dose transdermal nicotine replacement in cigarette smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Algorithms; Blood Pressure; Body Weight; Carbon Monoxide; Cotinine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nitrosamines; Pyridines; Smoking; Smoking Cessation | 2007 |